| Consensus‐based European guidelines for treatment of atopic eczema (atopic dermatitis) in adults and children: part I A Wollenberg, S Barbarot, T Bieber, S Christen‐Zaech, M Deleuran, ... Journal of the European Academy of Dermatology and Venereology 32 (5), 657-682, 2018 | 983 | 2018 |
| A randomized, controlled trial of oral propranolol in infantile hemangioma C Léauté-Labrèze, P Hoeger, J Mazereeuw-Hautier, L Guibaud, ... New England Journal of Medicine 372 (8), 735-746, 2015 | 825 | 2015 |
| Epidemiology of atopic dermatitis in adults: results from an international survey S Barbarot, S Auziere, A Gadkari, G Girolomoni, L Puig, EL Simpson, ... Allergy 73 (6), 1284-1293, 2018 | 780 | 2018 |
| Consensus‐based European guidelines for treatment of atopic eczema (atopic dermatitis) in adults and children: part II A Wollenberg, S Barbarot, T Bieber, S Christen‐Zaech, M Deleuran, ... Journal of the European Academy of Dermatology and Venereology 32 (6), 850-878, 2018 | 728 | 2018 |
| ETFAD/EADV Eczema task force 2015 position paper on diagnosis and treatment of atopic dermatitis in adult and paediatric patients A Wollenberg, A Oranje, M Deleuran, D Simon, Z Szalai, B Kunz, ... Journal of the European Academy of Dermatology and Venereology 30 (5), 729-747, 2016 | 525 | 2016 |
| Prognostic factors of CNS tumours in Neurofibromatosis 1 (NF1) A retrospective study of 104 patients JS Guillamo, A Creange, C Kalifa, J Grill, D Rodriguez, F Doz, S Barbarot, ... Brain 126 (1), 152-160, 2002 | 327 | 2002 |
| Topical corticosteroid phobia in atopic dermatitis: a study of its nature, origins and frequency H Aubert‐Wastiaux, L Moret, A Le Rhun, AM Fontenoy, JM Nguyen, ... British journal of dermatology 165 (4), 808-814, 2011 | 324 | 2011 |
| ETFAD/EADV Eczema task force 2020 position paper on diagnosis and treatment of atopic dermatitis in adults and children A Wollenberg, S Christen‐Zäch, A Taieb, C Paul, JP Thyssen, ... Journal of the European Academy of Dermatology and Venereology 34 (12), 2717 …, 2020 | 307 | 2020 |
| Efficacy and safety of upadacitinib vs dupilumab in adults with moderate-to-severe atopic dermatitis: a randomized clinical trial A Blauvelt, HD Teixeira, EL Simpson, A Costanzo, M De Bruin-Weller, ... JAMA dermatology 157 (9), 1047-1055, 2021 | 306 | 2021 |
| NF1 microdeletions in neurofibromatosis type 1: from genotype to phenotype E Pasmant, A Sabbagh, G Spurlock, I Laurendeau, E Grillo, MJ Hamel, ... Human mutation 31 (6), E1506-E1518, 2010 | 265 | 2010 |
| Patient‐Oriented SCORAD (PO‐SCORAD): a new self‐assessment scale in atopic dermatitis validated in Europe JF Stalder, S Barbarot, A Wollenberg, EA Holm, L De Raeve, S Seidenari, ... Allergy 66 (8), 1114-1121, 2011 | 258 | 2011 |
| Atopic dermatitis in the pediatric population: a cross-sectional, international epidemiologic study JI Silverberg, S Barbarot, A Gadkari, EL Simpson, S Weidinger, ... Annals of Allergy, Asthma & Immunology 126 (4), 417-428. e2, 2021 | 235 | 2021 |
| When does atopic dermatitis warrant systemic therapy? Recommendations from an expert panel of the International Eczema Council EL Simpson, M Bruin-Weller, C Flohr, MR Ardern-Jones, S Barbarot, ... Journal of the American Academy of Dermatology 77 (4), 623-633, 2017 | 227 | 2017 |
| Mosaic activating mutations in GNA11 and GNAQ are associated with phakomatosis pigmentovascularis and extensive dermal melanocytosis AC Thomas, Z Zeng, JB Rivière, R O’shaughnessy, L Al-Olabi, JS Onge, ... Journal of Investigative Dermatology 136 (4), 770-778, 2016 | 195 | 2016 |
| Effectiveness and safety of dupilumab for the treatment of atopic dermatitis in a real-life French multicenter adult cohort S Faiz, J Giovannelli, C Podevin, M Jachiet, JD Bouaziz, Z Reguiai, ... Journal of the American Academy of Dermatology 81 (1), 143-151, 2019 | 184 | 2019 |
| European guideline (EuroGuiDerm) on atopic eczema: part I–systemic therapy A Wollenberg, M Kinberger, B Arents, N Aszodi, G Avila Valle, S Barbarot, ... Journal of the European Academy of Dermatology and Venereology 36 (9), 1409-1431, 2022 | 167 | 2022 |
| Unravelling the genetic basis of variable clinical expression in neurofibromatosis 1 A Sabbagh, E Pasmant, I Laurendeau, B Parfait, S Barbarot, B Guillot, ... Human molecular genetics 18 (15), 2768-2778, 2009 | 167 | 2009 |
| Large congenital melanocytic nevi: therapeutic management and melanoma risk: a systematic review M Vourc'h-Jourdain, L Martin, S Barbarot Journal of the American Academy of Dermatology 68 (3), 493-498. e14, 2013 | 161 | 2013 |
| Report from the fourth international consensus meeting to harmonize core outcome measures for atopic eczema/dermatitis clinical trials (HOME initiative) JR Chalmers, E Simpson, CJ Apfelbacher, KS Thomas, L Von Kobyletzki, ... British Journal of Dermatology 175 (1), 69-79, 2016 | 144 | 2016 |
| Therapeutic patient education in atopic dermatitis: worldwide experiences JF Stalder, C Bernier, A Ball, L De Raeve, U Gieler, M Deleuran, ... Pediatric dermatology 30 (3), 329-334, 2013 | 143 | 2013 |
